81 related articles for article (PubMed ID: 19123480)
1. Identification of a rhabdomyosarcoma targeting peptide by phage display with sequence similarities to the tumour lymphatic-homing peptide LyP-1.
Witt H; Hajdin K; Iljin K; Greiner O; Niggli FK; Schäfer BW; Bernasconi M
Int J Cancer; 2009 May; 124(9):2026-32. PubMed ID: 19123480
[TBL] [Abstract][Full Text] [Related]
2. A tumor-homing peptide with a targeting specificity related to lymphatic vessels.
Laakkonen P; Porkka K; Hoffman JA; Ruoslahti E
Nat Med; 2002 Jul; 8(7):751-5. PubMed ID: 12053175
[TBL] [Abstract][Full Text] [Related]
3. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
[TBL] [Abstract][Full Text] [Related]
4. Imaging of alpha(v)beta(3) expression by a bifunctional chimeric RGD peptide not cross-reacting with alpha(v)beta(5).
Zannetti A; Del Vecchio S; Iommelli F; Del Gatto A; De Luca S; Zaccaro L; Papaccioli A; Sommella J; Panico M; Speranza A; Grieco P; Novellino E; Saviano M; Pedone C; Salvatore M
Clin Cancer Res; 2009 Aug; 15(16):5224-33. PubMed ID: 19671851
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells.
Laakkonen P; Akerman ME; Biliran H; Yang M; Ferrer F; Karpanen T; Hoffman RM; Ruoslahti E
Proc Natl Acad Sci U S A; 2004 Jun; 101(25):9381-6. PubMed ID: 15197262
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of a peptide with affinity to head and neck cancer.
Nothelfer EM; Zitzmann-Kolbe S; Garcia-Boy R; Krämer S; Herold-Mende C; Altmann A; Eisenhut M; Mier W; Haberkorn U
J Nucl Med; 2009 Mar; 50(3):426-34. PubMed ID: 19223422
[TBL] [Abstract][Full Text] [Related]
7. Identification and Tumour-Binding Properties of a Peptide with High Affinity to the Disialoganglioside GD2.
Müller J; Reichel R; Vogt S; Müller SP; Sauerwein W; Brandau W; Eggert A; Schramm A
PLoS One; 2016; 11(10):e0163648. PubMed ID: 27716771
[TBL] [Abstract][Full Text] [Related]
8. Targeting bladder tumor cells in vivo and in the urine with a peptide identified by phage display.
Lee SM; Lee EJ; Hong HY; Kwon MK; Kwon TH; Choi JY; Park RW; Kwon TG; Yoo ES; Yoon GS; Kim IS; Ruoslahti E; Lee BH
Mol Cancer Res; 2007 Jan; 5(1):11-9. PubMed ID: 17259343
[TBL] [Abstract][Full Text] [Related]
9. Identification of synovium-specific homing peptides by in vivo phage display selection.
Lee L; Buckley C; Blades MC; Panayi G; George AJ; Pitzalis C
Arthritis Rheum; 2002 Aug; 46(8):2109-20. PubMed ID: 12209516
[TBL] [Abstract][Full Text] [Related]
10. Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
Janssen ML; Oyen WJ; Dijkgraaf I; Massuger LF; Frielink C; Edwards DS; Rajopadhye M; Boonstra H; Corstens FH; Boerman OC
Cancer Res; 2002 Nov; 62(21):6146-51. PubMed ID: 12414640
[TBL] [Abstract][Full Text] [Related]
11. Furin targeted drug delivery for treatment of rhabdomyosarcoma in a mouse model.
Hajdin K; D'Alessandro V; Niggli FK; Schäfer BW; Bernasconi M
PLoS One; 2010 May; 5(5):e10445. PubMed ID: 20454619
[TBL] [Abstract][Full Text] [Related]
12. Selection of peptide ligands binding to the basolateral cell surface of proximal convoluted tubules.
Audigé A; Frick C; Frey FJ; Mazzucchelli L; Odermatt A
Kidney Int; 2002 Jan; 61(1):342-8. PubMed ID: 11786117
[TBL] [Abstract][Full Text] [Related]
13. (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression.
Li ZB; Cai W; Cao Q; Chen K; Wu Z; He L; Chen X
J Nucl Med; 2007 Jul; 48(7):1162-71. PubMed ID: 17574975
[TBL] [Abstract][Full Text] [Related]
14. Tumor targeting of baculovirus displaying a lymphatic homing peptide.
Mäkelä AR; Enbäck J; Laakkonen JP; Vihinen-Ranta M; Laakkonen P; Oker-Blom C
J Gene Med; 2008 Sep; 10(9):1019-31. PubMed ID: 18655234
[TBL] [Abstract][Full Text] [Related]
15. Neuroblastoma tumor cell-binding peptides identified through random peptide phage display.
Zhang J; Spring H; Schwab M
Cancer Lett; 2001 Oct; 171(2):153-64. PubMed ID: 11520599
[TBL] [Abstract][Full Text] [Related]
16. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
17. A specific heptapeptide from a phage display peptide library homes to bone marrow and binds to primitive hematopoietic stem cells.
Nowakowski GS; Dooner MS; Valinski HM; Mihaliak AM; Quesenberry PJ; Becker PS
Stem Cells; 2004; 22(6):1030-8. PubMed ID: 15536193
[TBL] [Abstract][Full Text] [Related]
18. Anti-angiogenesis activities of novel peptide complexes: mitochondria-disruptive 9mer peptides conjugated with the integrin alpha V beta 3-homing cyclic RGD motif.
Iwasaki T; Yamakawa M; Asaoka A; Kawano T; Ishibashi J
Biosci Biotechnol Biochem; 2012; 76(11):2044-8. PubMed ID: 23132564
[TBL] [Abstract][Full Text] [Related]
19. targeted drug delivery to hepatocarcinoma in vivo by phage-displayed specific binding peptide.
Du B; Han H; Wang Z; Kuang L; Wang L; Yu L; Wu M; Zhou Z; Qian M
Mol Cancer Res; 2010 Feb; 8(2):135-44. PubMed ID: 20145035
[TBL] [Abstract][Full Text] [Related]
20. Identification of peptide sequences that target to the brain using in vivo phage display.
Li J; Zhang Q; Pang Z; Wang Y; Liu Q; Guo L; Jiang X
Amino Acids; 2012 Jun; 42(6):2373-81. PubMed ID: 21792566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
